by Tiana Tonrey | Jun 18, 2019 | Press Release, Press Releases
Vitro Biopharma 2nd Quarter ended April 30th 2019 Financial Results of Operations Golden, Colorado-June 19th, 2019-Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced its 2nd quarter ended April 30th 2019 financial results of operations. Vitro...
by Tiana Tonrey | Apr 30, 2019 | Press Release, Press Releases
Golden, Colorado-April 30, 2019-Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma one of the world’s emerging biotechnology companies focused on allogeneic Mesenchymal Stem Cell (“MSC”) research and clinical products including AlloRx Stem Cells™, Brain Grow...
by Tiana Tonrey | Apr 29, 2019 | Press Release, Press Releases
Vitro Biopharma Obtains CLIA Certification Adding a New Dimension to its Ongoing Stem Cell Clinical Trials Golden, Colorado—April 2, 2019—Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma announced receipt of a Certificate of Compliance with CLIA (Clinical...
by Tiana Tonrey | Mar 24, 2019 | Press Release, Press Releases
Vitro Biopharma 1st Quarter ended January 31st 2019 Financial Results of Operations Golden, Colorado-March 21, 2018-Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced its 1st quarter ended January 31st 2019 financial results of operations. Vitro...
by Tiana Tonrey | Mar 14, 2019 | Press Release, Press Releases
Golden, Colorado—March 12, 2019—Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma announced receipt of provisional approval from the National Stem Cell Ethics Committee (NSCEC) of the Ministry of Health of the Commonwealth of the Bahamas for a clinical trial...
by Jim | Jan 24, 2019 | Press Release, Press Releases
Press Release Source: Vitro Diagnostics, Inc. Vitro Biopharma 2018 CEO Shareholder Letter:Record Revenues from Stem Cell Treatments Lead to 4th Quarter BreakevenCashflow & Growth...
